Business Context and Reporting Period
This Form 8-K Current Report was filed by Healthcare Trust of America, Inc. (NYSE: HTA) and Healthcare Trust of America Holdings, LP on September 17, 2021. The report discloses corporate governance changes and executive compensation arrangements effective as of August 2, 2021, and September 16, 2021.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive employment terms and equity awards.
Material Changes
- Executive Appointment: Peter N. Foss was appointed Interim President and Chief Executive Officer effective August 2, 2021, with a formal employment agreement executed on September 16, 2021.
- Board Leadership: W. Bradley Blair, II was elected Chairman of the Board effective August 2, 2021.
- Compensation Structure: New compensation packages were established for the Interim CEO and the new Board Chair, including base salary, performance bonuses, and restricted stock awards.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, financial outlook, or general management commentary regarding business operations. It details specific contractual terms for executive compensation:
- Interim CEO (Peter N. Foss):
- Annual base salary: $835,000.
- Target bonus: $1,237,000; Maximum bonus: $1,875,000 for the period September 1, 2021, to August 30, 2022.
- Restricted Stock Award: 105,660 shares vesting on the first anniversary of the agreement.
- Signing Bonus: $100,000 (clawback provision applies if terminated for Cause or resignation).
- Severance: One year of salary and target bonus (or maximum bonus in case of change in control) upon termination without Cause, Change in Control, or replacement by a permanent CEO.
- Board Chair (W. Bradley Blair, II):
- Restricted Stock Award: 17,593 shares vesting on the first anniversary of his election.
Investor Verification Checklist
- Verify the vesting schedule and performance criteria for the 105,660 restricted stock units granted to Peter N. Foss.
- Confirm the specific performance objectives required to achieve the target and maximum bonus amounts for the Interim CEO.
- Review the definition of "Corporate Transaction" and "Cause" within the attached Employment Agreement (Exhibit 10.1) to understand severance triggers.
- Monitor future filings for the appointment of a permanent CEO, which would terminate the current interim agreement.